Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Immune checkpoint blockade with anti-CTLA-4 and anti-PD-1 antibodies has shown promising results in the treatment of patients with advanced HCC. The anti-PD-1 antibody, nivolumab, is now approved for patien...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Immunol Immunother
Hoofdauteurs: Brown, Zachary J., Yu, Su Jong, Heinrich, Bernd, Ma, Chi, Fu, Qiong, Sandhu, Milan, Agdashian, David, Zhang, Qianfei, Korangy, Firouzeh, Greten, Tim F.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Berlin Heidelberg 2018
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6085109/
https://ncbi.nlm.nih.gov/pubmed/29959458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-018-2190-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items